(under,1)
(it,2)
(cells 
Our,1)
(Scale,1)
(setting 
Therefore,,1)
(screening,2)
(worthwhile 
Intervention,1)
(protease,1)
((RT-qPCR),1)
(been,10)
(end,1)
(enhanced,1)
(imaging,,1)
(prognoses,1)
(PCR 
The,1)
(mutation,5)
(motivations,1)
(epidermal,5)
(selective,3)
(insulin 
IR,1)
(OPAE,1)
(little,1)
(-3 3,1)
(prompting,1)
(invasiveness,1)
(conducted,6)
((stage,1)
(PI3K/Akt/mTOR,4)
(incorporation,1)
(indicated,3)
(8-12,1)
(therapy 
We,1)
(therapy ,1)
(fractionated,1)
(invasive,1)
(alone,1)
(0 12,1)
(optimization,1)
(patients 
,1)
(diagnosis,,1)
(proposed,1)
(purpose,1)
(vivo,5)
((WMS-R),1)
(owing,1)
(thus,1)
(leading,2)
(distinct,2)
(clinic 
,1)
(efficacies,1)
(account,1)
(manner 
Results,1)
(female,1)
(cervical,1)
(aimed,3)
(Kaplan-Meier,1)
(Function,1)
(metastasis 
This,1)
(tailor,1)
(OCT4 
3-O-p-Coumaroyltormentic,1)
(belongs,1)
(cytokines,1)
(confirmed,,1)
(chart,1)
(10%,1)
(short,2)
(Cox's,1)
(cohorts,1)
(summarized,1)
(on,28)
(implications,1)
((homogeneous,1)
(trial 
All,1)
(mean),1)
(and/or,2)
(﻿Extended,1)
(acquired,1)
(8 28,1)
(Culture,1)
(treatment,28)
(disease 
Endocrine,1)
(partial,2)
(respectively 
The,1)
(reduction,2)
(facilitate,2)
(acid,2)
(desire,,1)
((HER)2-positive,1)
(suppressing,2)
(AE37,,1)
(properties,2)
(low,1)
(CINAHL,,1)
(1 4mg/m2,1)
(cost-effective,,1)
(desire,1)
(2-dimensional,1)
(II,2)
(osteoclasts,1)
(technologies,1)
(﻿Bisphosphonate,1)
(right,1)
(5 years,4)
(EMBASE,,1)
(0 87-1 73;,1)
(activate,1)
(cell,39)
(colony,1)
(differences,2)
(greatest,1)
(epithelial,3)
(melanoma,1)
(patients,38)
(P13K/Akt/mTOR,1)
(chelation,1)
(h,1)
(metastatic,6)
(spatial,1)
(selected,1)
(photograph,1)
(isoforms,1)
(9 7% 
At,1)
(unfavourable,1)
(chemotherapy,,2)
(significant,8)
(immediate,4)
(detect,2)
(1 8,2)
(did,1)
((CXCL1),1)
(questionnaire,2)
(sequencing,2)
(lymph,1)
(promoter,1)
(provides,1)
(advanced,8)
(CSCs,1)
(dysfunctional,3)
(accounts,1)
(Insulin,1)
((ALDH)-expressing,1)
(systemic,4)
(prognostic,4)
(proteasome,1)
(2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic,1)
(cells 
We,1)
(anthracycline-based,1)
(there,1)
(SOX4,2)
(histology,,1)
(5-,1)
([one,2)
(2],1)
(protoscoleces,,1)
(disruptions,1)
(overexpression,1)
(pinch,1)
(breast 
Finally,,1)
(convolution,1)
(systems,1)
(2231,1)
(fair/poor 
Between,1)
(high,6)
(D538G,1)
(experience,1)
(related,3)
(undergoing,1)
(metastasis,8)
(therapeutic,6)
(recurrence,,2)
(treatment 
In,1)
(recurrences),1)
(brain,1)
(help,2)
(2,5)
(performed 
This,1)
((PFS),2)
(mice;,1)
(increased,1)
(specific,2)
(ones,1)
(PFS,4)
((MTT),1)
(dysfunction,4)
(integrated,1)
(secreted,1)
(time-enhancement,2)
(cytotoxicity,1)
(IR,5)
(disease,6)
(MTT,1)
(near-tetraploid,1)
(0 867,1)
(pivotal,1)
(sequencing,,1)
(virus,3)
(modeling,1)
(further,7)
(diseases 
Breast,1)
(key,1)
(voxel-basis 
Finally,,1)
(showing,1)
(context,1)
(enhancement) 
As,1)
(malignancies 
This,1)
(between,19)
(display,4)
(vasculature,,1)
(massive,1)
(TUBO,1)
(Collection,1)
(sponges,,1)
(hyperinsulinaemia,1)
(subtypes 
Nevertheless,,1)
(quantitative,3)
(regarding,1)
(occurred,,1)
(uniform,1)
(fermented,1)
(tissues),1)
(progesterone,,1)
